Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Mar 2026 for Elanco Animal Health Inc, €806k. Read the official filing
Filing timeline
BuySaleJeffrey N. Simmons
Insider track record
Disclosed buys
5
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+6.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jeffrey N. Simmons: trading record in brief
Jeffrey N. Simmons (chief executive) discloses dealings in 2 companies, chiefly Elanco Animal Health Inc and ELI LILLY & Co. We count 23 filings; the first trade dates from 26 January 2016 and the latest from 3 March 2026.
On the market, this insider has only ever bought: 5 purchases, €2.6M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 17 share grants and 1 option exercise.
Half of the purchases are above €426k and half below. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 5 March 2026, the filings show a share grant worth €806k in Elanco Animal Health Inc. The most recent open-market purchase was published on 15 December 2025, 307 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey N. Simmons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
37,898 shares@ US$24.8815.1% of flowCommon StockSEC:0001479079-26-000013:0
397,041 shares0Common StockSEC:0001479079-26-000011:0
22,000 shares@ US$21.74989.0% of flowCommon StockSEC:0001479079-25-000017:0
Canonical exit: 11 Mar 2026 (T+90)
265,252 shares0Common StockSEC:0001415889-25-007082:0
75,721 shares@ US$11.1716.2% of flowCommon StockSEC:0001415889-25-006627:0
449,408 shares0Common StockSEC:0001415889-25-005164:0
100,000 shares@ US$13.006123.7% of flowCommon StockSEC:0001415889-24-021121:0
Canonical exit: 10 Nov 2024 (T+90)
11,012 shares@ US$15.993.2% of flowCommon StockSEC:0001415889-24-007220:0
187,150 shares0Common StockSEC:0001415889-24-006648:0
148,084 shares0Common StockSEC:0001415889-24-005975:0
15,000 shares@ US$9.59812.7% of flowCommon StockSEC:0001415889-23-004744:0
Canonical exit: 8 Jun 2023 (T+90)
10,696 shares@ US$11.102.2% of flowCommon StockSEC:0001415889-23-004468:0
316,386 shares0Common StockSEC:0001415889-23-004353:0
12,662 shares@ US$11.262.7% of flowCommon StockSEC:0001415889-23-004289:0
30,000 shares@ US$14.53828.7% of flowCommon StockSEC:0001415889-22-009497:0
Canonical exit: 8 Dec 2022 (T+90)
10,688 shares@ US$27.955.0% of flowCommon StockSEC:0001415889-22-002744:0
88,114 shares0Common StockSEC:0001415889-22-002472:0
229,655 shares0Common StockSEC:0001179110-22-001597:0
15,814 shares@ US$33.668.5% of flowCommon StockSEC:0001179110-21-009594:0
16,850 shares@ US$29.708.0% of flowCommon StockSEC:0000950138-21-000410:0
Canonical exit: 9 Nov 2021 (T+90)
9,843 sharesCommon StockSEC:0000059478-16-000310:0
4,553 sharesCommon StockSEC:0000059478-16-000310:1
19,344 sharesCommon StockSEC:0000059478-16-000270:0
23 of 23 declarations
